EMV Capital is a deep tech and life sciences venture capital investment group with an international portfolio of high-growth companies. The firm focuses on generating superior returns for investors by investing in, managing, and strengthening early-stage IP-rich companies. EMV Capital's proactive management style aims to advance companies to critical value inflection points, utilizing a capital-efficient investment model that includes balance sheet investments and syndicated investments. The firm operates through three capital sources: capital-efficient investments through its PLC balance sheet, fund management of the Evergreen EIS and Martlet Capital Funds, and syndicated investments leveraging its extensive network of third-party investors. Headquartered in London, with offices in Cambridge and strong international links, EMV Capital is quoted on the AIM market of the London Stock Exchange.
Is EMV Capital the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with EMV Capital, along with a list of other relevant VCs, is available on Hopohopo.io.
Investment role
Lead and follow
Stages
Seed, Series A
First ticket size
£100,000 - £3,400,000
When engaging EMV Capital, founders should highlight defensible IP, clear pathways to value inflection, and capital efficiency in their business model. Demonstrate how your technology or science-driven solution can scale with disciplined resource allocation and articulate the milestones that will unlock significant valuation steps. Emphasize your openness to collaborative, hands-on investor involvement and your readiness to leverage syndication or co-investment structures to accelerate growth.
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.